5 Am Venture Management, LLC Portfolio Holdings

5 Am Venture Management, LLC

  • $149 Million
  • Q3 2025

5 Am Venture Management, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $149 Million distributed in 25 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Entrada Therapeutics, Inc. with a value of $24.7M, Pharvaris N.V. with a value of $19.9M, Centessa Pharmaceuticals PLC with a value of $16.5M, Viridian Therapeutics, Inc.\De with a value of $15.8M, and Eye Point Pharmaceuticals, Inc. with a value of $14.5M.

Examining the 13F form we can see an increase of $46K in the current position value, from $149M to 149M.

5 Am Venture Management, LLC is based out at San Francisco, CA

Below you can find more details about 5 Am Venture Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $149 Million
Healthcare: $149 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$266M
$24.7 Million 16.56% of portfolio
4,256,379
Q3 2025 Reduced 1.21%
$795M
$19.9 Million 13.35% of portfolio
797,600
Q4 2023 Added 35.74%
$2.6B
$16.5 Million 11.08% of portfolio
680,945
Q3 2025 Reduced 18.05%
$1.15B
$15.8 Million 10.63% of portfolio
736,595
Q1 2024 Added 25.57%
$404M
$14.5 Million 9.75% of portfolio
1,050,000
Q3 2024 Added 2,000.0%
$652M
$13.1 Million 8.81% of portfolio
939,298
Q1 2024 Added 69.25%
$1.2B
$12.9 Million 8.63% of portfolio
497,270
Q4 2023 Added 60.27%
$315M
$11.8 Million 7.9% of portfolio
5,405,404
Q2 2024 New
$728M
$8.19 Million 5.49% of portfolio
572,665
Q1 2024 Added 41.61%
$62.1M
$3.48 Million 2.33% of portfolio
800,000
Q4 2024 New
$102M
$2.95 Million 1.98% of portfolio
995,841
Q4 2024 New
$247M
$2.47 Million 1.66% of portfolio
476,200
Q1 2024 New
$20.6M
$2 Million 1.34% of portfolio
3,630,724
Q1 2023 Reduced 2.68%
$75.8M
$739,000 0.5% of portfolio
490,000
Q2 2023 New
Mersana Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Artiva Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 14.25%
Surrozen Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Skye Bioscience Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 2.33%
Camp4 Therapeutics Corp
-
$0 0.0% of portfolio
-
Q3 2025 Added 100.45%
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 62.93%
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 41.59%
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 50.0%
Adverum Biotechnologies Inc
-
$0 0.0% of portfolio
-
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 25
  • Current Value $149 Million
  • Prior Value $149 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 1 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track 5 Am Venture Management, LLC Portfolio

Follow 5 Am Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 5 Am Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 5 Am Venture Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email